Prevention of Esophageal Varices clinical trials at University of California Health
1 research study open to eligible people
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
open to eligible people ages 18-75
This seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, multicenter, parallel-groups, placebo-controlled study will assess the efficacy, safety, and tolerability of belapectin compared with placebo in patients with nonalcoholic steatohepatitis (NASH) cirrhosis and clinical signs of portal hypertension but without esophageal varices at baseline.
Our lead scientists for Prevention of Esophageal Varices research studies include Rohit Loomba, MD.